BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32348981)

  • 1. Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level.
    Flemming KD; Kumar S; Brown RD; Singh RJ; Whitehead K; McCreath L; Lanzino G
    Cerebrovasc Dis; 2020; 49(2):216-222. PubMed ID: 32348981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations.
    Flemming KD; Kumar S; Brown RD; Lanzino G
    World Neurosurg; 2020 Jan; 133():e767-e773. PubMed ID: 31605843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort.
    Li D; Wu ZY; Liu PP; Ma JP; Huo XL; Wang L; Zhang LW; Wu Z; Zhang JT
    J Neurosurg; 2020 Mar; 134(3):917-928. PubMed ID: 32168479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic Cavernous Malformation Presenting with Seizure without Hemorrhage: Analysis of Factors Influencing Clinical Presentation.
    Agosti E; Flemming KD; Lanzino G
    World Neurosurg; 2019 Sep; 129():e387-e392. PubMed ID: 31132505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Physical Activity on Cavernous Malformation Hemorrhage.
    Joseph NK; Kumar S; Lanzino G; Flemming KD
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104629. PubMed ID: 32147026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
    Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
    J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhage from cerebral cavernous malformations: The role of associated developmental venous anomalies.
    Chen B; Herten A; Saban D; Rauscher S; Radbruch A; Schmidt B; Zhu Y; Jabbarli R; Wrede KH; Kleinschnitz C; Sure U; Dammann P
    Neurology; 2020 Jul; 95(1):e89-e96. PubMed ID: 32513786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there differences in clinical presentation, radiologic findings, and outcomes in female patients with cavernous malformation?
    Flemming KD; Lanzino G
    Acta Neurochir (Wien); 2023 Jul; 165(7):1855-1861. PubMed ID: 37306819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Pregnancy on Hemorrhage Risk in Women With Cerebral and Spinal Cavernous Malformations.
    Joseph NK; Kumar S; Brown RD; Lanzino G; Flemming KD
    Stroke; 2021 Jan; 52(2):434-441. PubMed ID: 33493052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhage risks and functional outcomes of untreated brainstem cavernous malformations.
    Li D; Hao SY; Jia GJ; Wu Z; Zhang LW; Zhang JT
    J Neurosurg; 2014 Jul; 121(1):32-41. PubMed ID: 24785325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.
    Ma L; Zhang S; Li Z; Wu CX; Wang Z; Zhan L; Hao Q; Wang H; Ye X; Chen X; Liu YO; Wang S; Zhao YL
    Stroke; 2020 Oct; 51(10):2997-3006. PubMed ID: 32951540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patients.
    Alalfi MO; Lanzino G; Flemming KD
    J Neurosurg; 2023 Oct; 139(4):1018-1024. PubMed ID: 36933254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Select Medications on Prospective Hemorrhage Risk in Patients with Spinal or Cerebral Cavernous Malformations.
    Previch L; Lanzino G; Brown RD; Flemming KD
    World Neurosurg; 2022 Jul; 163():e678-e683. PubMed ID: 35364298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cause is the main predictor of outcome in patients with pontine hemorrhage.
    Rabinstein AA; Tisch SH; McClelland RL; Wijdicks EF
    Cerebrovasc Dis; 2004; 17(1):66-71. PubMed ID: 14530640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.
    Josephson CB; Leach JP; Duncan R; Roberts RC; Counsell CE; Al-Shahi Salman R;
    Neurology; 2011 May; 76(18):1548-54. PubMed ID: 21536634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infratentorial Developmental Venous Abnormalities and Inflammation Increase Odds of Sporadic Cavernous Malformation.
    Kumar S; Lanzino G; Brinjikji W; Hocquard KW; Flemming KD
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1662-1667. PubMed ID: 30878367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis.
    Gross BA; Du R
    J Neurosurg; 2017 Apr; 126(4):1079-1087. PubMed ID: 27203143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between trauma and acute hemorrhage of cavernous malformations in children: report of 3 cases.
    Fanous AA; Jowdy PK; Lipinski LJ; Balos LL; Li V
    J Neurosurg Pediatr; 2016 Sep; 18(3):263-8. PubMed ID: 27153379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, natural history, and outcomes for infantile intracranial cavernous malformations: case series and systematic review of the literature.
    Goyal A; Fernandes-Torres J; Flemming KD; Williams LN; Daniels DJ
    Childs Nerv Syst; 2023 Jun; 39(6):1545-1554. PubMed ID: 36917267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.
    Horne MA; Flemming KD; Su IC; Stapf C; Jeon JP; Li D; Maxwell SS; White P; Christianson TJ; Agid R; Cho WS; Oh CW; Wu Z; Zhang JT; Kim JE; Ter Brugge K; Willinsky R; Brown RD; Murray GD; Al-Shahi Salman R;
    Lancet Neurol; 2016 Feb; 15(2):166-173. PubMed ID: 26654287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.